Lamperd Less Lethal, Inc.
LLLI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.29 | -0.03 | 0.19 | -0.37 |
| FCF Yield | 0.00% | -11.38% | -0.86% | -3.91% |
| EV / EBITDA | -28.38 | -8.87 | -21.70 | -13.97 |
| Quality | ||||
| ROIC | 37.33% | 92.25% | 33.56% | 112.71% |
| Gross Margin | 60.01% | 85.16% | 78.69% | -140.52% |
| Cash Conversion Ratio | 0.44 | 0.06 | 0.41 | 0.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -23.21% | -2.38% | -26.79% | -30.38% |
| Free Cash Flow Growth | 0.00% | -821.42% | 89.86% | 4.57% |
| Safety | ||||
| Net Debt / EBITDA | -11.49 | -4.97 | -9.22 | -3.49 |
| Interest Coverage | -64.37 | -150.92 | -137.24 | -283.13 |
| Efficiency | ||||
| Inventory Turnover | 0.04 | 0.04 | 0.04 | 0.56 |
| Cash Conversion Cycle | -11,562.36 | -9,296.14 | -11,286.36 | -474.56 |